SignalsMonitor LIVE INTELLIGENCE
GENERALQUIET

9 days ago

FDA: mifepristone review won’t be done until March

FDA: mifepristone review won’t be done until March

What's happening

SignalsMonitor is following this as a general story. The Hill is the outlet attached so far. The first report grouped here was at 8 Oct 2026, 02:33 UTC. The headline in use is “FDA: mifepristone review won’t be done until March”. This note is SignalsMonitor's own briefing, not the publisher's article.

What we know

The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it won’t impose any new restrictions on the pill before that point. The revelations are likely to further anger anti-abortion activists, who have…

The HillRead at The Hill

Story timeline

Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.

Reported by 1 outlet

  • The Hill